Hamid Khoja
Vermogen: 3 553 $ op 31-05-2026
Vermogen: 3 553 $ op 31-05-2026
Hamid Khoja is currently Chief Scientific Officer at FibroBiologics, Inc. since 2021.
Formerly, worked as Principal Scientist at Covaris LLC from 2009 to 2021, and as Scientist at Chiron Corp.
and Eli Lilly & Co. Education includes a doctorate from Boston University and an undergraduate degree from the University of Southern California.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
FIBROBIOLOGICS, INC. 0,06% | 04-05-2026 | 3.063 ( 0,06% ) | 3 553 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| FIBROBIOLOGICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
Covaris LLC
Covaris LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets instruments, consumables & reagents | Corporate Officer/Principal | 01-08-2021 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Hoofd Techniek/Wetenschap/O&O | - |
| ELI LILLY AND COMPANY | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Covaris LLC
Covaris LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets instruments, consumables & reagents | Health Technology |
FibroBiologics, Inc.
FibroBiologics, Inc. BiotechnologyHealth Technology Develops and commercializes fibroblast-based cell therapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau